ADMET (Absorption, Distribution, Metabolism, Elimination, Toxicity) research forms a critical part of drug discovery and development.
In vitro, ADME-Tox and DMPK studies are no longer late-stage regulatory requirements but are now an essential part of early discovery. We offer a comprehensive range of products and services for ADME-Tox research suitable to support regulatory approval, and advance discovery.
We offer a range of human biomaterials to support this new approach to early-stage ADME-Tox including:
- Cell Products